Rockshield Capital Corp. (CSE:RKS), (US:CRUOF), (FSE:6BC) (“Rockshield” or the “Company”) is pleased to provide an update on the company’s investment portfolio.
Over the past 6 months the nascent blockchain industry has experienced incredible growth driven by the price appreciation of various crypto currencies and the increased awareness of the potential benefits this new technology could unlock. With the overall growth of the industry there have been a number of investment opportunities that have emerged both in the private and public markets and Rockshield has been diligently reviewing countless opportunities and to date has invested in a number of blockchain companies that we think are best positioned to capitalize on this emerging global industry.
Leveraging our professional network we have gained access to a number of investments at early stage private rounds that are attractively priced and should position Rockshield to capture significant value appreciation as these companies expand operations and go public providing investment liquidity. In addition to continuing to screen for attractive investment opportunities the Company is reviewing opportunities to unlock the value of our private holdings potentially by way of a spin out into separate public market vehicles in order to generate further shareholder returns.
We have recently updated our corporate website ( to provide greater clarity into our investment strategy and current holdings in the cannabis, blockchain, healthcare and resources sectors and we will look to provide a more detailed summary of the recent investments we have made in the blockchain and cannabis industry shortly.
Dave Doherty, President and CEO said “We are extremely pleased with the portfolio of blockchain and cannabis companies we have invested in, as we think we have backed some of the best management teams in the business, with professional and scalable operations, that are well positioned to prosper within the their respective industries. In addition we continue to evaluate various strategies to unlock the value of our holdings in order to maximize shareholder returns”.
Rockshield is an actively managed venture capital fund and merchant bank, focused on small cap high growth companies. Rockshield’s management team has been seed financing and investing in early stage venture companies for over the past 20 years and performs extensive due diligence as it looks to build a portfolio of opportunistic investments with the aim of generating superior long-term returns while managing risks. Leveraging the vast professional network and experience of the management team, Rockshield has early access to private and public deals and reviews hundreds of deals a year selecting only those with the best potential returns.
For further information regarding Rockshield, see Rockshield’s disclosure documents on SEDAR at The Canadian Securities Exchange has neither approved nor disapproved the information contained herein and does not accept responsibility for the adequacy or accuracy of this news release.
Rockshield Capital Corp.
David Doherty
President and CEO
Dan Sorger


The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less

The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.

Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.

Keep reading... Show less

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .

Keep reading... Show less
  • On November 19 , the Mexican Senate passed comprehensive adult-use cannabis legalization, moving Mexico towards becoming one of the few countries to legalize cannabis nationally
  • On March 31, 2020 , the Company entered into an agreement with Tecnologico de Monterrey , the leading university in Mexico , to educate physicians across Latin America , in advance of the impending regulations in Mexico
  • To date, close to 550 LatAm physicians have obtained their diploma accrediting completion of Khiron’s medical education program
  • The Company plans to deploy its ZereniaTM medical cannabis clinics and telehealth strategy in Mexico , building on the success of its vertical integration strategy in Colombia
  • Expanding the Zerenia clinic strategy will build on the Company’s Colombia knowledge and proven distribution capabilities, with rapid telehealth service adoption and over 5,600 medical cannabis scripts filled to date
  • Mexico represents one of the largest potential markets for medical cannabis in the world and is anticipated to reach $1.2bn USD by 2028 (Prohibition Partners).
  • Company to release Q3 2020 financials and host webcast on Tuesday, December 1st

Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ), (OTCQX: KHRNF), ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe welcomes the passing of adult-use cannabis legislation by the Mexican Senate, which moves the country closer to a legalized cannabis market, and towards provision for medical cannabis products.  Khiron has had a presence in Mexico since 2018 and has been working with doctors and medical institutions to develop a deep understanding of the market.

Keep reading... Show less

Recap of special management call includes upcoming corporate milestones and details of proposed combination with established beverage manufacturer

Emerging leader in infused cannabis beverages, BevCanna Enterprises Inc. (CSE:BEV, OTCQB:BVNNF, FSE:7BC) (“BevCanna” or the “Company”) is pleased to provide a recorded recap of the special management call held on Tuesday November 24, 2020. The call discussed upcoming corporate milestones and reviewed recent developments at the developer and manufacturer of cannabinoid‐infused beverages and consumer products for in‐house brands and white label clients.

Keep reading... Show less